Medical Device Coatings

Report Code: HLC049B

Publish Date: Nov 2008

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global medical device coatings market will increase from an estimated $4.2 billion in 2008 to $4.7 billion in 2009. It should reach $7.5 billion in 2014, a compound annual growth rate (CAGR) of 9.9%.
The NAFTA region has the largest share of the market with an estimated $2.1 billion in sales in 2008. This is expected to increase to $2.4 billion in 2009 and $3.9 billion in 2014, for a CAGR of 10.2%.
The European Union has the second largest share of the market and is expected to generate $1.1 billion in 2008. This should increase slightly in 2009 and reach $2.0 billion in 2014, for a CAGR of 10.6%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This study examines the most rapidly changing sector of the global medical device business. It describes technological and regulatory developments that have influenced the direction of this dynamic industry and also forecasts the global and regional requirements for coating and kindred treatment technologies through 2014.

REASON FOR DOING THE STUDY

In 2006, BCC Research published Medical Device Coatings (HLC049A), a comprehensive study that quantified the extent to which coating materials were being used to improve the functionality, longevity, and cost-effectiveness of medical devices. At that time, BCC noted several key trends. Chief among these was the rapid acceptance of drug-eluting coatings by the medical community, which had spurred interest in the technology on the part of both coating suppliers and device makers. Responding to the new technology, the regulatory community began to proactively adapt itself to encourage the development of coated devices. In the U.S., the Food and Drug Administration (FDA) had created a new office to focus on combination products (e.g., coated stents) that had crossed the regulatory boundaries between drugs and devices.

The earlier BCC study also noted the emergence of pure-play medical device-coating enterprises, several of which were the outgrowth of university-based commercialization programs. Finally it predicted that the future path of development would be typical of many new technologies in that it would be strewn with unanticipated difficulties that would emerge only as products moved off the lab bench and into the commercial pipeline.

Since that 2006 study, the medical device coatings industry has developed more or less along the path that most had anticipated. There have also been reversals, including highly visible product recalls. Not surprisingly, bureaucratic realities have dampened initial optimism regarding swift product approvals. Blue sky projections for rapid growth have been clouded by unanticipated patent litigation, and in the case of start-ups, competition from larger and more financially robust companies has created obstacles. A dearth of financial assistance for initial public offerings has further contributed to dampening enthusiasm. Nonetheless, the secular trends driving the industry remain strong. As the Baby Boom generation ages, the medical outcome advantages of coated implants become more evident, and the spirit of innovation continues to infuse the industry with fresh ideas and institutional support from universities and government funding agencies.

The net effect has been that the medical device coating industry has been growing at less than the predicted 12.4% compound annual growth rate (CAGR), although still at an impressive rate. In this study, which covers the period from 2009 through 2014, BCC forecasts a 9.9% CAGR as this promising industry matures into an essential sector of the world economy.

INTENDED AUDIENCE

This study will be of interest to the medical device industry; the coating industry; suppliers of alloys, ceramics, polymers, and other materials used in the manufacturing of coatings; manufacturers of chemicals, pharmaceuticals, and energy sources that can be incorporated into coatings; coating and medical device importers; and medical device contract manufacturers. It will also provide useful insights for those exploring investments in this vibrant and growing segment of the medical device industry.

SCOPE OF REPORT

The scope of this study is the same as our 2006 investigation of the industry. It looks at medical device coatings industry from the perspective of the coating producer, the manufacturer, and the end-user. This study differs in the way the data have been organized. In the previous report, regional demand was divided on the basis of national income with the U.S. separated as a distinct market. Since then, the medical device coatings industry has begun to divide itself along regional patterns that follow similarities in regulatory behavior. As a result, this report adopts a regional division consisting of the North American Free Trade Agreement (NAFTA) countries, the European Union (E.U.), Other Developed Countries outside of those two major trade locks, and the Rest of the World. Coating technologies are separated on the basis of their underlying chemistry and physics, resulting in eight categories. Finally, the demand in terms of devices used in the 22 areas of medical specialty is examined. The result is a report containing nearly 150 tables, 55 of which provide U.S. dollar-value requirement coatings for 2005, 2008, 2009, and 2014.

We present requirement forecasts by type of technology, by regions of the world in which the devices are used, and by medical specialty. To this end we distinguish among:

Eight technologies
Four regions of the world
Twenty-two medical specialties

The eight technologies, which comprise seven classes of coatings, are grouped on the basis of their most noteworthy chemical or characteristic and all treatment processes that do not use coating materials. For example, chrome plating is considered an alloy. Surface texturing, regardless of whether it is the product of acid etching or laser vaporization, is considered a surface treatment. The technology groups are:

Alloy
Ceramic
Combination
Energy-absorbing and optical
Energy-emitting
Micro and nano
Protective polymer
Surface treatment

The four regions in which devices are used are:

North American Free Trade Agreement (NAFTA) countries, (i.e., Canada, Mexico, and the U.S., including Puerto Rico)
European Union (E.U.) (i.e., the 27 member countries as of 2008-09-15)
Other Developed Nations (i.e., the 39 countries that BCC considers to have economies and medical device regulations comparable to those of NAFTA and E.U. countries.
Rest of the World

TWENTY-TWO MEDICAL SPECIALITIES

The BCC listing expands upon the FDA medical specialties grouping by separating several areas that are combined by the FDA. For example, the FDA treats gastroenterology and urology as one group for the purpose of device review. In the table entitled Medical Devices By Type and Variation, BCC follows the FDA practice of using combined areas in reporting the number of types of devices (i.e., 4,432) and device variations (i.e., 106,768), but the study provides separate dollar-value forecasts for gastroenterology and urology products. Similarly, many devices used in hospital settings are also used by outpatients. The FDA combines hospital and personal use products for device review purposes. Here, BCC also provides separate forecasts. Some products have significant use in several medical specialties. In those cases, the study includes those devices in the listings for that specialty. Forecasted values proportionately reflect use in that medical specialty. Forecasts are therefore provided for the following 22 medical specialties.enty-two Medical Specialties

Anesthesia
Cardiovascular
Clinical medicine
Clinical toxicology
Dental
Ear, nose, and throat
Gastroenterology
General hospital
General surgery
Hematology
Immunology
Microbiology
Neurology
Obstetrics and gynecology
Ophthalmology
Orthopedics
Pathology
Personal use
Physical medicine
Radiology
Respiratory therapy
Urology

The country groupings have also been changed. In BCC’s 2006 study, regions were grouped in a manner that reflected World Bank income levels. Since then, considerable efforts have been undertaken to consolidate and harmonize device regulation among the two major trade blocks—the North American Free Trade Agreement (NAFTA) nations and the European Union (E.U.) nations. As a result, trade in medical devices is now more strongly driven by regulatory than gross economic conditions. Reflecting that reality, this study reports the U.S. as part of NAFTA and identifies the E.U. as a separate region.

The study also includes more precise forecasts for medical specialties. In BCC’s earlier report, only values for those medical specialties that were expected to make significant use of coatings within the original forecast period, which concluded in 2010, were reported. Since then, coatings have come into general use in 22 medical and healthcare specialties for which comprehensive FDA data is available. Hence, in this report, BCC is able to provide separate use by coating technology and use by region forecasts for all 22 areas.

Finally, to harmonize the present work with the 2006 study, BCC has included a column showing 2005 forecast values as redistributed to reflect the previously described NAFTA/E.U. regional reporting format. The redistributed data for 2005 presented in this report is also more accurate than that available when the 2006 report went to press. Consequently, the value for coatings at the producer price level has been adjusted downward by $16 million (i.e., from $2,960 million in the 2006 report to $2,944 million).

A special note to purchasers of the 2006 study:The mostobvious change is that BCC now presents forecast values at the million-dollar rather than billion-dollar level.

METHODOLOGY

The FDA recognizes more than 106,000 different types of medical devices distributed among nearly 4,400 general types of products. In this study, BCC focuses on the subset of those products that are currently benefiting or will soon benefit from the addition of coatings (e.g., drug-eluting polymers) or surface treatments (e.g., texturing) to improve performance or enhance patient safety.

In this study, BCC reports values at the producer price level, shown to the nearest $1 million. Values are in current U.S. dollars and are not adjusted to compensate for inflation.

INFORMATION SOURCES

BCC Research studied approximately 250 companies to obtain data for this study, including coating manufacturers, medical device manufacturers, and pharmaceutical companies. Also reviewed were reports and studies prepared by the FDA and comparable foreign regulatory agencies; organizations representing physicians, surgeons, hospital administrators, and trade and professional associations; foreign government trade associations; and insurers. In addition, data were compiled from the FDA medical device data registry, the U.S. Security and Exchange Commission corporate filings database, and the U.S. Patent and Trademark office.

ANALYST’S CREDENTIALS

James Wilson prepared the original version of this study, Medical Device Coating (HLC049A), published in 2006. He is the author of more than 300 articles and several books dealing with science, medicine, technology, and business. Formerly the editor of the Princeton Business Journal and a senior science and technology editor for Hearst Magazines, he is a member of the National Association of Science Writers and American Medical Writers Association. He has served on the adjunct faculty of Temple University and on the staffs of Drexel University and the Academy of Natural Sciences. His previous medical-related studies for BCC include Controlled Release Technologies (MST027G).

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com

[+] Show Chapter Details

Title/Chapter Name	Pages	Member Price
Full Report: Medical Device Coatings	269	Free
Chapter- 1: INTRODUCTION	6	Free
STUDY GOAL AND OBJECTIVES REASONS FOR DOING THE STUDY INTENDED AUDIENCE SCOPE OF REPORT METHODOLOGY INFORMATION SOURCES ANALYST's CREDENTIALS RELATED BCC WORK CREDENTIALS BCC ONLINE SERVICES DISCLAIMER
Chapter- 2: SUMMARY	2	Free
Table Summary : GLOBAL MEDICAL DEVICE COATING MARKET, BY REGION, THROUGH 2014 Figure Summary : GLOBAL MEDICAL DEVICE COATING MARKET, BY REGION, 2009 AND 2014
Chapter- 3: INDUSTRY OVERVIEW	7	Free
THE EVOLVING MEDICAL DEVICE COATING INDUSTRY INTERNATIONAL COOPERATION AND HARMONIZATION
Chapter- 4: THE MEDICAL DEVICE COATINGS COMMUNITY	10	Free
NATIONALLY BASED ORGANIZATIONS THE CONTINUING IMPORTANCE OF ACADEMIC RESEARCH COATING PURCHASERS AND BUYING INFLUENCES COATING SUPPLIERS
Chapter- 5: THE FDA AND THE COATING INDUSTRY	11	Free
CONTROL CLASS DESIGNATION COATINGS LEAD TO A NEW PRODUCT CATEGORY FDA PANEL ASSIGNMENTS SEGMENT THE MARKET COATING-RELATED RECALLS
Chapter- 6: PATENT ANALYSIS	10	Free
Table 6 : MEDICAL DEVICE COATING PATENTS ISSUED SINCE 1976 Table 7 : KEY DRUG-RELATED COATING PATENTS Table 8 : HEPARIN-RELATED COATING PATENTS Table 9 : STENT-RELATED COATING PATENTS
Chapter- 7: FACTORS DRIVING COATING DEMAND	8	Free
BOOMERS REACH MEDICARE AGE THE MEDICARE NOSOCOMIAL INFECTION INITIATIVE UNCERTAIN IMPACT OF MEDICAL TOURISM ON COATINGS
Chapter- 8: ASSESSING COATING REQUIREMENTS	7	Free
REGIONAL DEFINITIONS NORTH AMERICAN FREE TRADE AGREEMENT COUNTRIES EUROPEAN UNION OTHER DEVELOPED NATIONS REST OF THE WORLD Table 13 : THREE PERSPECTIVES ON THE COATINGS MARKET
Chapter- 9: 2009 TO 2014 REQUIREMENT FORECASTS BY COATING TECHNOLOGY	45	Free
ALLOY COATING TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR ALLOY TECHNOLOGIES CERAMIC COATING TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR CERAMIC-BASED TECHNOLOGIES COMBINATION PRODUCT COATING TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR COMBINATION PRODUCT TECHNOLOGIES ENERGY-ABSORBING TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR ENERGY-ABSORBING COATING TECHNOLOGIES ENERGY-EMITTING TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR ENERGY-EMITTING TECHNOLOGIES MICRO- AND NANO-COATINGS GLOBAL REQUIREMENT FORECAST FOR MICRO AND NANO TECHNOLOGIES PROTECTIVE POLYMER COATINGS GLOBAL REQUIREMENT FORECAST FOR PROTECTIVE POLYMER TECHNOLOGIES SURFACE TREATMENT TECHNOLOGIES GLOBAL REQUIREMENT FORECAST FOR SURFACE TREATMENT TECHNOLOGIES Table 19 : REQUIREMENT FOR MEDICAL DEVICE COATINGS, BY TECHNOLOGY, THROUGH 2014 Figure 2 : GLOBAL REQUIREMENT FOR COATING MATERIALS, 2014 Table 20 : REQUIREMENT FOR ALL COATING TECHNOLOGIES, BY ALL MEDICAL SPECIALTIES, THROUGH 2014
Chapter- 10: 2009 TO 2014 REQUIREMENT FORECASTS BY MEDICAL SPECIALTY	91	Free
ANESTHESIA DEVICE COATING REQUIREMENTS CARDIOVASCULAR MEDICINE CLINICAL MEDICINE CLINICAL TOXICOLOGY DENTISTRY EAR, NOSE, AND THROAT GASTROENTEROLOGY GENERAL AND PLASTIC SURGERY GENERAL HOSPITAL USE DEVICES HEMATOLOGY IMMUNOLOGY MICROBIOLOGY NEUROLOGY OBSTETRICS AND GYNECOLOGY OPHTHALMOLOGY ORTHOPEDICS PATHOLOGY PERSONAL USE PHYSICAL MEDICINE RADIOLOGY RESPIRATORY THERAPY UROLOGY Table 30 : FACTORS INFLUENCING THE REQUIREMENT FOR NEW COATINGS
Chapter- 11: APPENDIX A: BUSINESSES WITH SIGNIFICANT INDUSTRY INVOLVEMENT	22	Free
4TH STATE ABBOTT LABORATORIES ACCORD BIOMATERIALS ACRYMED ADHESIVE CONSULTANTS ADVANCED MEDICAL OPTICS ADVANSOURCE BIOMATERIALS AEONCLAD COATING AFFINERGY AGION TECHNOLOGIES ALCON ALL-CHEMIE ALLVIVO VASCULAR ANGIOTECH PHARMACEUTICALS ARMOLOY OF CONNECTICUT AST PRODUCTS BACTERIN INTERNATIONAL BAXTER HEALTHCARE BIOCOAT BIOCOMPATIBLES INTERNATIONAL BIOMET BIOPHAN BOSTON SCIENTIFIC BRISTOL-MYERS SQUIBB CARDIOTECH INTERNATIONAL CARMEDA CERAC CERAGENIX PHARMACEUTICALS CONOR MEDSYSTEMS CORDIS CORIN GROUP COVALON CURTISS-WRIGHT METAL TREATMENT CV THERAPEUTICS DEPUY ORTHOPAEDICS EDWARDS LIFESCIENCES HEMOTEQ HYDROMER I-FLOW JAPAN MEDICAL MATERIALS JOHNSON & JOHNSON LOMBARD MEDICAL TECHNOLOGIES MC3 MEDTRONIC CARDIOVASCULAR MICRUS ENDOVASCULAR MIV THERAPEUTICS NANOCOPOEIA NERITES NIPPON ELECTRIC GLASS NOVARTIS PHARMA NUCRYST PHARMACEUTICALS PARA TECH COATING PARYLENE COATING SERVICES POLYMERIX SMITH & NEPHEW SONO-TEK SPECIALTY COATING SYSTEMS SPIRE ST. JUDE MEDICAL STRYKER SURFACE SOLUTIONS LABS SURMODICS TECHNI-MET THORATEC TYRX PHARMA WRIGHT MEDICAL TECHNOLOGY WYETH ZEBRA TECHNOLOGIES ZIMMER HOLDINGS
Chapter- 12: APPENDIX B: ABSTRACTS OF KEY COATING PATENTS	50	Free
ADHERENT FLEXIBLE HYDROGEL AND MEDICATED COATINGS AMINOGUANIDINYL- AND ALKOXYGUANIDINYL-SUBSTITUTED PHENYL ACETAMIDES AS PROTEASE INHIBITORS AN APPARATUS FOR COATING TUBULAR MEMBERS ANGIOTENSIN-(1-7) ELUTING POLYMER-COATED MEDICAL DEVICE TO REDUCE RESTENOSIS ANTIBIOTIC BONDING OF VASCULAR PROSTHESES AND OTHER IMPLANTS ANTI-INFECTIVE COVERING FOR PERCUTANEOUS AND VASCULAR ACCESS DEVICE AND COATING METHOD ANTITHROMBOGENIC MEMBRANE MIMETIC COMPOSITIONS AND METHODS ANTITHROMBOGENIC RETENTIVE CATHETER APPARATUS AND METHOD FOR ELECTROSTATIC SPRAY COATING OF MEDICAL DEVICES APPARATUS AND PROCESS FOR COATING ARTICLES APPARATUS AND METHOD FOR COATING IMPLANTABLE DEVICES BACTERICIDAL COATINGS FOR IMPLANTS BI-LAMINAR, HYALURONAN COATINGS WITH SILVER-BASED ANTIMICROBIAL PROPERTIES BIOCOMPATIBLE CARRIER CONTAINING ACTINOMYCIN D CERAMIC CARDIAC ELECTRODES BIOACTIVE AGENT-RELEASE COATING BIOMEDICAL MATERIAL FOR IMPROVING THE ADHESION AND PROLIFERATION OF CELLS AND A MODIFIED ARTIFICIAL VESSEL BIOACTIVE COATING COMPOSITION AND METHODS BIOABSORBABLE BRACHYTHERAPY DEVICE BIOPROSTHETIC HEART VALVES WITH HIGH CALCIFICATION RESISTANCE BIOSTATIC COATINGS FOR THE REDUCTION AND PREVENTION OF BACTERIAL ADHESION BLOOD CIRCULATION APPARATUS COUPLING DEVICE THAT IMPROVES BIOCOMPATIBILITY OF INNER SURFACES WITH TREATED BLOOD METHODS AND IMPLANTS FOR PROVIDING RADIATION TO A PATIENT COATED ORTHOPEDIC IMPLANT COMPONENTS COLLAGEN-IMPREGNATED DACRON GRAFT COATED ENDOVASCULAR STENT COATING DISPENSING SYSTEM AND METHOD USING A SOLENOID HEAD FOR COATING MEDICAL DEVICES COATING INTRALUMINAL STENTS COATED ORTHOPEDIC IMPLANT COMPONENTS COMPOSITION COMPRISING HEPARIN AS A NONTHROMBOGENIC SURFACE COATING AGENT COMPOSITION FOR COATING AN IMPLANTABLE PROSTHESIS CORONARY STENT WITH A RADIOACTIVE RADIOPAQUE COATING DEVICE AND PROCESS FOR COATING STENTS DEVICE FOR PROTECTING MEDICAL DEVICES DURING A COATING PROCESS DRUG-RELEASE STENT COATING PROCESS DRUG-POLYMER-COATED STENT WITH PEGYLATED STYRENIC BLOCK COPOLYMERS ECHOGENIC COATINGS EPTFE SMALL CALIBER VASCULAR GRAFTS WITH SIGNIFICANT PATENCY ENHANCEMENT VIA A SURFACE COATING WHICH CONTAINS COVALENTLY BONDED HEPARIN ETHYLENE VINYL ALCOHOL-DIMETHYL ACETAMIDE COMPOSITION AND A METHOD OF COATING A STENT FIBRIN-COATED POLYMER SURFACES FLUORINATING POLYMER SURFACES FUNCTIONALIZED POLYURETHANES GLAUCOMA SHUNT AND A METHOD OF MAKING AND SURGICALLY IMPLANTING OF SAME GRAFT POLYMERIZATION OF SUBSTRATE SURFACES GRAFTING OF BIOCOMPATIBLE HYDROPHILIC POLYMERS ONTO INORGANIC AND METAL SURFACES HEMOCOMPATIBLE COATINGS ON HYDROPHOBIC POROUS POLYMERS HEPARIN DELIVERY METHOD HIGHLY CROSSLINKED, EXTREMELY HYDROPHOBIC NITRIC OXIDE-RELEASING POLYMERS HYDROPHILIC POLYVINYLBUTYRAL ALLOYS HYDROPHILIC POLYMER BLEND INTRAVASCULAR STENT AND METHOD LOCAL DRUG DELIVERY LUBRICIOUS HYDROPHILIC COATING FOR AN INTRACORPOREAL MEDICAL DEVICE MECHANICAL AND ACOUSTICAL SUSPENSION COATING OF MEDICAL IMPLANTS MEDICAL DEVICE WITH SURFACE MODIFICATION WITH SUPEROXIDE DISMUTASE MIMIC MEDICAL DEVICES WITH DURABLE AND LUBRICIOUS POLYMERIC COATING METHOD AND APPARATUS FOR POLYMER APPLICATION TO INTRACORPOREAL DEVICE METHOD FOR ATTACHMENT OF BIOMOLECULES TO MEDICAL DEVICE SURFACES METHOD FOR COATING AN IMPLANTABLE DEVICE AND SYSTEM FOR PERFORMING THE METHOD METHOD FOR COATING IMPLANTABLE DEVICES METHOD FOR DELIVERING A THERAPEUTIC SUBSTANCE TO A BODY LUMEN METHOD FOR ETCHING A MICROPATTERNED MICRODEPOT PROSTHESIS METHOD AND APPARATUS FOR COATING AN IMPLANTABLE DEVICE METHODS OF COATING AN IMPLANTABLE DEVICE HAVING DEPOTS FORMED IN A SURFACE THEREOF METHOD OF FORMING A THERAPEUTIC COATING ONTO A SURFACE OF AN IMPLANTABLE PROSTHESIS MEDICAL DEVICE HAVING SURFACE MODIFICATION WITH SUPEROXIDE DISMUTASE MIMIC METHODS FOR COATING IMPLANTS METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SYNTHETIC POLYMERS METHOD OF REDUCING PROTEIN DEPOSITION IN SIGHT CORRECTION DEVICES METHODS AND CLINICAL DEVICES FOR THE INHIBITION OR PREVENTION OF MAMMALIAN CELL GROWTH METHOD FOR FINE BORE ORIFICE SPRAY COATING OF MEDICAL DEVICES AND PREFILMING ATOMIZATION METHOD FOR IMPARTING A BIOACTIVE COATING METHOD FOR MAKING AND MEASURING A COATING ON THE SURFACE OF A MEDICAL DEVICE USING AN ULTRAVIOLET LASER METHOD FOR MANUFACTURING MEDICAL ARTICLES COMPOSED OF SILICONE RUBBER COATED WITH COLLAGEN METHOD FOR GROWING AN ALUMINA SURFACE ON ORTHOPAEDIC IMPLANT COMPONENTS METHOD OF FABRICATING A BIOCOMPATIBLE STENT METHOD FOR MICROPOROUS SURFACE MODIFICATION OF IMPLANTABLE METALLIC MEDICAL ARTICLES METHOD FOR PRETREATING THE SURFACE OF A MEDICAL DEVICE METHOD FOR ROLL COATING MULTIPLE STENTS METHOD FOR SPRAY COATING A MEDICAL DEVICE HAVING A TUBULAR WALL SUCH AS A STENT METHOD FOR SPRAY COATING MEDICAL DEVICES METHOD FOR SPRAY-COATING A MEDICAL DEVICE HAVING A TUBULAR WALL SUCH AS A STENT METHOD FOR TREATING MEDICAL DEVICES USING GLYCEROL AND AN ANTIMICROBIAL AGENT METHOD OF MAKING ANTIMICROBIAL POLYMERIC SURFACES METHOD TO STABILIZE TDMAC HEPARIN COATING METHODS FOR POLYMERIC COATINGS STENTS METHODS FOR SURFACE MODIFICATION METHODS OF FORMING A COATING FOR A PROSTHESIS METHODS OF POLYMER IMPREGNATION MICROPOROUS COVERED STENTS AND METHOD OF COATING NONIRRITATING ANTIMICROBIAL COATING FOR MEDICAL IMPLANTS NUCLEIC ACID COATING COMPOSITIONS AND METHODS OPTIMIZED DOSING FOR DRUG COATED STENTS PALLADIUM-COATED IMPLANT PHOTOACTIVATABLE NUCLEIC ACIDS PHYSICAL VAPOR DEPOSITION OF RADIOPAQUE MARKINGS ON A GRAFT STERILIZATION OF BIOACTIVE COATINGS PLASMA-CROSSLINKED HYDROPHILIC COATING POROUS PROSTHESIS AND A METHOD OF DEPOSITING SUBSTANCES INTO THE PORES POLYBIFUNCTIONAL REAGENT WITH A POLYMERIC BACKBONE AND LATENT REACTIVE MOIETIES AND BIOACTIVE GROUPS POLYCARBONATE-POLYURETHANE DISPERSIONS FOR THROMBO-RESISTANT COATINGS POLYMER-COATED STENT STRUCTURE POLYMERIC COATINGS CONTAINING A PH BUFFER AGENT POLYURETHANES GRAFTED WITH POLYETHYLENE OXIDE CHAINS CONTAINING COVALENTLY BONDED HEPARIN PREPARATION OF OPHTHALMIC COMPOSITIONS PROCESS FOR COATING A SURFACE OF A METALLIC STENT PROCESS FOR COATING A SURFACE OF A STENT PROCESS FOR COATING A SURFACE OF A STENT PROCESS FOR IMPREGNATING A POROUS MATERIAL WITH A CROSSLINKABLE COMPOSITION PROCESS FOR PREPARING SURFACE MODIFICATION SUBSTANCES RADIOACTIVE BALLOON FOR DILATION CATHETER SYSTEM AND PROCESS FOR PREPARATION RADIOACTIVE MEDICAL DEVICES RADIOACTIVE SEED IMPLANTS RESIN COMPOSITION AND MANUFACTURING METHOD SELECTIVE COATING OF MEDICAL DEVICES SEMIAUTOMATIC COATING SYSTEM METHODS FOR COATING MEDICAL DEVICES SILYL AND HEPARIN COMPOSITIONS SOFT X-RAY EMITTING RADIOACTIVE STENT STENT COATING DEVICE STENT COATING STENT WITH ANTITHROMBOGENIC COATING STENT WITH RADIOPAQUE COATING CONSISTING OF PARTICLES IN A BINDER SURFACE COATING AGENTS SURFACE FEATURES OF AN IMPLANTABLE MEDICAL DEVICE SURGICAL LUBRICANTS THERAPEUTIC USE OF POLYMERS THERAPEUTIC, DIAGNOSTIC, OR HYDROPHILIC COATING FOR AN INTRACORPOREAL MEDICAL DEVICE THROMBO-RESISTANT NONTHROMBOGENIC OBJECTS FORMED FROM RESIN-GRAPHITE MIXTURES TRIGGERED RELEASE HYDROGEL DRUG-DELIVERY SYSTEM VARIABLE SURFACE AREA STENT VASCULAR BIOMATERIAL DEVICES VASCULAR BIOMATERIAL VASCULAR PROSTHESIS AND METHOD OF MAKING THE SAME VASCULAR PROSTHESIS HAVING A COMPOSITE STRUCTURE WATER-SOLUBLE COATING AGENTS BEARING INITIATOR GROUPS ZWITTERIONIC MATERIALS ZWITTERIONIC POLYMER BLEND MATERIALS ZWITTERIONIC POLYMERS

Published - Apr-2006| Analyst - Jim Wilson| Code - HLC049A

Report Highlights

The value of worldwide sales for all categories of coatings and surface treatment processes used in manufacturing medical devices reached $2.96 billion in 2005.
Fueled by an explosive growth in high-value combination products, such as arterial stents and antimicrobial-coated catheters, the global medical device coatings business will experience an average annual growth rate (AAGR) of 12.4%, reaching worldwide sales of $5.31 billion by 2010.
The swift acceptance of drug-eluting stents as a "gold standard" treatment by surgeons around the globe suggests that the demand for other coated versions of existing medical devices will be equally swift. Our analysis further suggests that there will be a correspondingly swift acceptance of new coated devices as they are introduced.

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Medical Device Coatings

Report Highlights

Table of Contents

Report Highlights

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight